Cas:85327-13-5 2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one manufacturer & supplier

Chemical Name:2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one

CAS.NO:85327-13-5

Synonyms:EINECS 286-671-2;Spiro(isobenzofuran-1(3H),9′-(9H)xanthen)-3-one,2′-(cyclohexyl(phenylmethyl)amino)-6′-(diethylamino);2′-(Benzyl(cyclohexyl)amino)-6′-(diethylamino)spiro(isobenzofuran-1(3H),9′-(9H)xanthene)-3-one;2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)-3H-spiro[2-benzofuran-1,9′-xanthen]-3-one

Molecular Formula:C₃₇H₃₈N₂O₃

Molecular Weight:558.70900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:759ºC at 760 mmHg

Density:1.26g/cm3

Index of Refraction:1.674

PSA:42.01000

Exact Mass:558.28800

LogP:8.44010

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EINECS 286-671-2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)-3H-spiro[2-benzofuran-1,9′-xanthen]-3-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Spiro(isobenzofuran-1(3H),9′-(9H)xanthen)-3-one,2′-(cyclohexyl(phenylmethyl)amino)-6′-(diethylamino) Use and application,Spiro(isobenzofuran-1(3H),9′-(9H)xanthen)-3-one,2′-(cyclohexyl(phenylmethyl)amino)-6′-(diethylamino) technical grade,usp/ep/jp grade.

Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017). 2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one manufacturer Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. 2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one supplier J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 2′-[benzyl(cyclohexyl)amino]-6′-(diethylamino)spiro[2-benzofuran-3,9′-xanthene]-1-one factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.